New clinical trial investigates aspirin as part of new treatment for triple negative breast cancer

By | August 17, 2021
An innovative new study is trialing whether giving aspirin, commonly used as pain relief, alongside immunotherapy drug avelumab could improve its effectiveness for people affected by breast cancer.